Olink Proteomics announces a new oncology-focused biomarker panel that expands its protein library to over 1100 high-quality assays | Olink Proteomics
![Frontiers | Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease Frontiers | Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease](https://www.frontiersin.org/files/Articles/889647/fneur-13-889647-HTML/image_m/fneur-13-889647-g001.jpg)
Frontiers | Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer's Disease
![Olink Proteomics on Twitter: "A recent Nature publication by C Teunissen reveals new Alzheimer's Disease biomarkers with great diagnostic potential A broad screen of 11 Olink Target 96 panels analyzing a large Olink Proteomics on Twitter: "A recent Nature publication by C Teunissen reveals new Alzheimer's Disease biomarkers with great diagnostic potential A broad screen of 11 Olink Target 96 panels analyzing a large](https://pbs.twimg.com/media/FiPbjP7XkAAiHIH.jpg)
Olink Proteomics on Twitter: "A recent Nature publication by C Teunissen reveals new Alzheimer's Disease biomarkers with great diagnostic potential A broad screen of 11 Olink Target 96 panels analyzing a large
![Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF | JACC: Heart Failure Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF | JACC: Heart Failure](https://www.jacc.org/cms/asset/ba3f8205-e7ba-4b71-b044-5616ea1b393e/fx1.jpg)
Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF | JACC: Heart Failure
![Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications | Nature Communications Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-28639-4/MediaObjects/41467_2022_28639_Fig1_HTML.png)
Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications | Nature Communications
![DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE DISCOVERY LIFE SCIENCES INSTALLS THE LARGEST OLINK PLATFORM IN THE AMERICAS TO SUPPORT PROTEOMICS RESEARCH & BIOMARKER DEVELOPMENT AT SCALE](https://mma.prnewswire.com/media/1902152/Olink_Logo_for_Distribution_Logo.jpg?p=facebook)